There's also the PBC (Public Benefit Corporation), which in addition to profit / shareholder value explicitly defines positive impact on society as a goal, and exists since 2010 in some states, while in others only since 2022 [1]. But as far as I understand there are no legal requirements or audits that ensure those goals are followed.
Kagi (the search engine, popular in the HN community and I'm a happy customer myself) is one example of a PBC [2].
My experience interacting with Novo Nordisk is that, in their case, this model has led to massive inefficiencies.
The non-profit aspect has led to lots of internal politics and rigged hires. They are much more inefficient than a classical pharma.
Smells like tax evasion, but what do i know. Isn't IKEAs founder one of the richest people in Swiss?
Novo Nordisk might return to a more realistic market cap once other GLP-1 agonists enter the market, e.g. Lilly's.